CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Incontinence - urinary, in women - Management
What dose of duloxetine should be used?
- For the management of stress urinary incontinence:
- The recommended dose of duloxetine is 40 mg twice a day.
- Re-assess after 2–4 weeks of treatment to evaluate the benefit and tolerability of the treatment.
- If adverse effects are likely to be a problem, consider starting treatment at a dose of 20 mg twice a day for 2 weeks before increasing to the recommended dose of 40 mg twice a day.
- For information on treatment reduction and discontinuation, see Drug withdrawal or dose reduction.
[ABPI Medicines Compendium, 2008a]
© NHS Institute for Innovation and Improvement